The University of Washington School of Medicine Institute for Protein Design (IPD) has partnered with Nvidia to develop an ...

An entity of Swedish private equity firm EQT has agreed to acquire Qiagen for €10.8 billion (about $12.1 billion) cash, both said today, in a deal that would take private the global life-sciences ...

IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics.

The companies plan to first optimize Takara's SMART-seq RNA-seq library prep workflows on SPT Labtech's firefly liquid ...

A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies ...

The list of tools includes SpliceA12, a new iteration of a genomic AI model designed to identify disease-relevant splice ...

ASHG President Susan Slaugenhaupt, PhD, opened the society’s Montreal meeting with a heartfelt address of hope, leadership, ...

Limiting expansion steps to three days could increase the proportion of naive T cells in, and speed up the production of, CAR T-cell therapies.

Under the terms of the pharma deal, Enodia will screen, optimize, and develop Sec61 inhibitor candidates against multiple ...

PacBio and Verily Health will integrate HiFi long-read sequencing with health data and cloud tools to support biomedical ...

Results provide framework for uncovering regulatory variants in other X chromosome neurodevelopmental genes that may ...

Strategic automation and flexible bioprocessing could help cell and gene therapies scale across diverse APAC markets.